HOUSE DOCKET, NO. 1176        FILED ON: 1/18/2017

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1146

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Claire D. Cronin

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to the prescription monitoring program.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Claire D. Cronin

11th Plymouth

1/18/2017

Carole A. Fiola

6th Bristol

 

Robert M. Koczera

11th Bristol

 

Michelle M. DuBois

10th Plymouth

 

James J. Dwyer

30th Middlesex

 

Brian M. Ashe

2nd Hampden

 

Hannah Kane

11th Worcester

 

Paul Brodeur

32nd Middlesex

 

Kimberly N. Ferguson

1st Worcester

 

Kevin J. Kuros

8th Worcester

 


HOUSE DOCKET, NO. 1176        FILED ON: 1/18/2017

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1146

By Ms. Cronin of Easton, a petition (accompanied by bill, House, No. 1146) of Claire D. Cronin and others relative to the prescription monitoring program.  Public Health.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninetieth General Court
(2017-2018)

_______________

 

An Act relative to the prescription monitoring program.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

Subsection (c) of Section 24A of Chapter 94C shall hereby be amended by inserting the following paragraph after the first paragraph of this subsection:

For the purposes of monitoring the prescribing, ordering, and dispensing of all schedule II to V, inclusive, controlled substances and additional drugs, as authorized by subsection (a), the department shall promulgate regulations requiring that each opioid treatment program, as certified by Substance Abuse and Mental Health Services Administration pursuant to 42 CFR Part 8, that delivers a schedule II to V, inclusive, controlled substance or a substance classified as an additional drug by the department to the ultimate user shall submit to the department, by electronic means, information regarding each prescription or medical order dispensed for a drug included under subsection (a); and (2) a requirement that each pharmacy collects and reports, for each prescription or medical order dispensed for a drug under subsection (a), a customer identification number and other information associated with the customer identification number, as specified by the department. Each opioid treatment program shall submit the information in accordance with transmission methods and frequency requirements promulgated by the department; provided, however, that the information shall be submitted at least once every 24 hours. The department may issue a waiver to an opioid treatment program that is unable to submit prescription information by electronic means. The waiver shall permit the pharmacy to submit prescription information by other means promulgated by the department; provided, however, that all information required in this section is submitted in this alternative format.